Countryfocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia Summary GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts. In 2013, Indonesias population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an increase in net migration and a drop in the death rate. The countrys pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the countrys medical device market was worth $573m. The positive trends in the Indonesian healthcare market can primarily be attributed to - Increasing coverage of healthcare insurance - Improved access to healthcare facilities Scope - Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers - Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets: PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia Farma, PT Darya-Varia Laboratoria Tbk and PT Indofarma Tbk - An insightful review of the reimbursement and regulatory landscape,...